Skip to main content
Erschienen in: Indian Journal of Gastroenterology 4/2016

20.07.2016 | Short Report

Causes of liver disease and its outcome in HIV-infected individuals

verfasst von: Suryanarayana Bettadpura Shamanna, Ramavath Raghu Ramulu Naik, Abdoul Hamide

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Liver disease in HIV-infected patients has remained unaddressed in India. This study describes the causes of liver disease in HIV-infected patients and short-term outcome in them. Designed as a prospective observational study, it was conducted at Jawaharlal Institute of Postgraduate Medical Education and Research between September 2011 and March 2013. All consecutive HIV patients (>13 years) attending the antiretroviral therapy clinic or admitted in the Medicine Department were screened, and patients with liver disease or with either HBsAg or anti-HCV antibody positivity were included in the study. Of the 198 patients screened, 51 (26 %) had either abnormal liver function test or had HBsAg or anti-HCV positivity. The median age of the patients was 40 years and 82 % were males. The median CD4 count was 123 cells/mm3. Eighteen (35 %) of them had alcoholic liver disease. Six patients had probable hepatic involvement due to tuberculosis. Ten patients had antituberculosis drug-induced hepatotoxicity. One patient had acute hepatitis B and seven patients had chronic hepatitis B. The cause could not be established in 10 patients (20 %). After a median period of 8 months of follow up, 23 patients had improved, 19 patients (37 %) had died, and six patients had been lost to follow up. Of the patients who had died, 11 patients (58 %) had tuberculosis, and 6 patients (30 %) had decompensated alcoholic liver disease. In conclusion, liver disease in HIV-infected patients was associated with high mortality. Alcohol abuse, tuberculosis, and antituberculosis drugs were the major causes.
Literatur
1.
Zurück zum Zitat Soriano V, Barreiro P, Sherman KE. The changing epidemiology of liver disease in HIV patients. AIDS Rev. 2013;15:25–31.PubMed Soriano V, Barreiro P, Sherman KE. The changing epidemiology of liver disease in HIV patients. AIDS Rev. 2013;15:25–31.PubMed
2.
Zurück zum Zitat Rathi PM, Amarapurkar DN, Borges NE, et al. Spectrum of liver diseases in HIV infection. Indian J Gastroenterol 1997;16:94–5. Rathi PM, Amarapurkar DN, Borges NE, et al. Spectrum of liver diseases in HIV infection. Indian J Gastroenterol 1997;16:94–5.
5.
Zurück zum Zitat Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003;5:36–43.PubMed Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003;5:36–43.PubMed
6.
Zurück zum Zitat Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935–52.CrossRefPubMed Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935–52.CrossRefPubMed
9.
Zurück zum Zitat Easwaran M, Bazroy J, Jayaseelan V, et al. Prevalence and determinants of alcohol consumption among adult men in a coastal area of South India. Int J Med Sci Public Health. 2015;4:360–4. Easwaran M, Bazroy J, Jayaseelan V, et al. Prevalence and determinants of alcohol consumption among adult men in a coastal area of South India. Int J Med Sci Public Health. 2015;4:360–4.
10.
Zurück zum Zitat Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. Int J Behav Med. 2014;21:811–20.CrossRefPubMedPubMedCentral Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. Int J Behav Med. 2014;21:811–20.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Hickey AJ, Gounder L, Moosa MY, et al. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis 2015;15:209. Hickey AJ, Gounder L, Moosa MY, et al. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis 2015;15:209.
12.
Zurück zum Zitat Ali AH, Belachew T, Yami A, et al. Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study. PLoS One 2013; doi: 10.1371/journal.pone.0064622. Ali AH, Belachew T, Yami A, et al. Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study. PLoS One 2013; doi: 10.​1371/​journal.​pone.​0064622.​
14.
Zurück zum Zitat Rivero A, Mira JA, Pineda JA. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother. 2007;59:342–6.CrossRefPubMed Rivero A, Mira JA, Pineda JA. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother. 2007;59:342–6.CrossRefPubMed
15.
Zurück zum Zitat Hamide A, Shamanna SB, Balaguru S, et al. Long-term outcome of HIV-infected patients treated at a tertiary care hospital in southern India. Natl Med J India. 2014;27:134–7.PubMed Hamide A, Shamanna SB, Balaguru S, et al. Long-term outcome of HIV-infected patients treated at a tertiary care hospital in southern India. Natl Med J India. 2014;27:134–7.PubMed
16.
Zurück zum Zitat Sud A, Singh J, Dhiman RK, et al. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001;22:90–2.PubMed Sud A, Singh J, Dhiman RK, et al. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001;22:90–2.PubMed
17.
Zurück zum Zitat Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol 2006;12:6879–83. Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol 2006;12:6879–83.
18.
Zurück zum Zitat Saravanan S, Velu V, Kumarasamy N, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13:5015–20.CrossRefPubMedPubMedCentral Saravanan S, Velu V, Kumarasamy N, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13:5015–20.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Puoti M, Spinetti A, Ghezzi A, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000;24:211–7.CrossRefPubMed Puoti M, Spinetti A, Ghezzi A, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000;24:211–7.CrossRefPubMed
20.
Zurück zum Zitat Sharma SK, Soneja M, Prasad KT, et al. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India. Indian J Med Res. 2014;139:154–60.PubMedPubMedCentral Sharma SK, Soneja M, Prasad KT, et al. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India. Indian J Med Res. 2014;139:154–60.PubMedPubMedCentral
Metadaten
Titel
Causes of liver disease and its outcome in HIV-infected individuals
verfasst von
Suryanarayana Bettadpura Shamanna
Ramavath Raghu Ramulu Naik
Abdoul Hamide
Publikationsdatum
20.07.2016
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 4/2016
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-016-0676-6

Weitere Artikel der Ausgabe 4/2016

Indian Journal of Gastroenterology 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.